APA (7th ed.) Citation

Yurgelun-Todd, D. A., Renshaw, P. F., Goldsmith, P., Uz, T., & Macek, T. A. (2020). A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects. Psychopharmacology, 237(2), 317. https://doi.org/10.1007/s00213-019-05366-1

Chicago Style (17th ed.) Citation

Yurgelun-Todd, Deborah A., Perry F. Renshaw, Paul Goldsmith, Tolga Uz, and Thomas A. Macek. "A Randomized, Placebo-controlled, Phase 1 Study to Evaluate the Effects of TAK-063 on Ketamine-induced Changes in FMRI BOLD Signal in Healthy Subjects." Psychopharmacology 237, no. 2 (2020): 317. https://doi.org/10.1007/s00213-019-05366-1.

MLA (9th ed.) Citation

Yurgelun-Todd, Deborah A., et al. "A Randomized, Placebo-controlled, Phase 1 Study to Evaluate the Effects of TAK-063 on Ketamine-induced Changes in FMRI BOLD Signal in Healthy Subjects." Psychopharmacology, vol. 237, no. 2, 2020, p. 317, https://doi.org/10.1007/s00213-019-05366-1.